Endo International plc, a specialty pharmaceutical company, has announced changes to its executive leadership and senior management team. Under the new management structure, Endo's US branded pharmaceuticals and US generics business units, as well ... Individual.com, 2 months ago
Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'
A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive ...Morningstar.com, 4 weeks ago The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts Pharmacy Choice, 1 month ago The Generic Drugs Market: 2015 2030 - Opportunities, Challenges, Strategies & Forecasts Research and Markets, 1 month ago
More from: Town Hall, Town Hall...and 37 other sources
[embedded content] The National Association of Boards of Pharmacy (NABP) and the Anti-Diversion Industry Working Group (ADIWG), a consortium of pharmaceutical manufacturers and distributors, has created this educational video for pharmacists to ...Pharmacy Practice News, 3 weeks ago
Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and Swot Investigation
FEATURED COMPANIES 3M Ascend Therapeutics Endo International Janssen Pharmaceuticals Novartis ProStrakan MORE This is a comprehensive account of the market size, ...Research and Markets, 1 month ago
A federal judge tossed out a liability lawsuit filed against brandmakers Wyeth and Alaven Pharmaceuticals, saying they were not responsible for the death of a patient who took generic Reglan not made by the companies. The judge, from the Northern ...FDA News, 2 months ago
Biologics Red Blood Cells Leukocytes Reduced 012FQ04913, 012FQ05179, 012FS57190, 012FS57579, 012FS57591, 012FS57702, 012FS57778, 012FS61639, 012FT79545, 012FX26887, 012FX26897, 012FY36206, 012GZ29716, 012GZ29727, ...U.S. Food and Drug Administration, 2 weeks ago
Operator Good day, ladies and gentlemen, and welcome to the Q4 2014 Endo International plc earnings conference call. My name is Garda, and I'll be your operator for today. [Operator Instructions] I would now like to turn the conference over to ...Seeking Alpha, 4 weeks ago Endo International's revenues increase $800 million to 37% in fourth quarter 2014 News-Medical.Net, 4 weeks ago Endo Reports Fourth Quarter And Full Year 2014 Financial Results TickerTech.com, 4 weeks ago Endo International Reports Fourth Quarter And Full Year 2014 Financial Results BioSpace, 4 weeks ago
Insights from Soros Fund Management's 4Q holdings (Part 3 of 10) ( Continued from Part 2 ) Soros addsEndo International to its portfolio In the quarter ending December 31, 2014, Soros Fund Management added a significant new position inEndo ...Yahoo! Finance, 1 month ago
Highlights of Chilton Investment Company's 13F holdings for 4Q14 (Part 3 of 10) ( Continued from Part 2 ) Chilton Investment and Endo International Chilton Investment Company started new positions in Sonic Corporation (SONC), Endo ...Yahoo! Finance, 1 month ago Glenview Capital raises position in Endo International Yahoo! Finance, 2 months ago
Devices The Siemens Symbia S series is intended for use by appropriately trained health care professionals to aid in detecting, localizing, diagnosing, staging and restaging of lesions, tumors, disease and organ function for the evaluation ...U.S. Food and Drug Administration, 2 months ago
on your WebpageAdd Widget >Get your members hooked!